// App-Quantinova.ai

4594 : Quantifying the absolute benefit of neoadjuvant chemotherapy followed by definitive therapy in patients with muscle-invasive bladder cancer A systematic review and meta-analysis.

Researchers

Presenter

  • Waleed Ikram

Principal Investigators

  • Syed Arsalan Ahmed Naqvi

  • Ammad Raina

  • Ezza Fatima

  • Rabbia Siddiqi

  • Mahnoor Islam

  • Noureen Asghar

  • Kaneez Zahra Rubab Khakwani

  • Ahsan Masood Khan

  • Syed A. Hussain

  • Alan Haruo Bryce

  • Irbaz Bin Riaz

  • Parminder Singh

Medical Centers

  • Mayo Clinic, Phoenix, AZ

  • Midwestern University, Sierra Vista, AZ

  • UPMC Mckeesport, Mckeesport, PA

  • Dow University of Health Sciences, Karachi, Pakistan,

  • University of Arizona, Tucson, AZ

  • University of Arizona, Tucson, AZ

  • University of Michigan, Dexter, MI

  • Mayo Clinic Arizona, Phoenix, AZ

  • Department of Surgery, Mayo Clinic, Phoenix, AZ

Locations

  • United States

  • Pakistan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved